Bitter I - Search Results

1

Efficacy and tolerability of olanzapine in patients with schizophrenia in lithuania: A 13-week, multicenter, open-label, nonrandomized study.

Maciulis V, Bitter I, Milasiunas R, Dembinskas A, Radavicius L, Kaunas A, Dossenbach M, Walker D. Maciulis V, et al. Among authors: bitter i. Curr Ther Res Clin Exp. 2004 Jan;65(1):57-69. doi: 10.1016/S0011-393X(04)90005-7. Curr Ther Res Clin Exp. 2004. PMID: 24936104 Free PMC article.

2

Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia.

Bitter I, Dossenbach MR, Brook S, Feldman PD, Metcalfe S, Gagiano CA, Füredi J, Bartko G, Janka Z, Banki CM, Kovacs G, Breier A; Olanzapine HGCK Study Group. Bitter I, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jan;28(1):173-80. doi: 10.1016/j.pnpbp.2003.09.033. Prog Neuropsychopharmacol Biol Psychiatry. 2004. PMID: 14687871 Clinical Trial.

3

Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.

Dossenbach M, Erol A, el Mahfoud Kessaci M, Shaheen MO, Sunbol MM, Boland J, Hodge A, O'Halloran RA, Bitter I; IC-SOHO Study Group. Dossenbach M, et al. Among authors: bitter i. J Clin Psychiatry. 2004 Mar;65(3):312-21. J Clin Psychiatry. 2004. PMID: 15096069

4

Antipsychotic treatment and sexual functioning in first-time neuroleptic-treated schizophrenic patients.

Bitter I, Basson BR, Dossenbach MR. Bitter I, et al. Int Clin Psychopharmacol. 2005 Jan;20(1):19-21. doi: 10.1097/00004850-200501000-00004. Int Clin Psychopharmacol. 2005. PMID: 15602111 Clinical Trial.

5

Effectiveness of clozapine, olanzapine, quetiapine, risperidone, and haloperidol monotherapy in reducing hostile and aggressive behavior in outpatients treated for schizophrenia: a prospective naturalistic study (IC-SOHO).

Bitter I, Czobor P, Dossenbach M, Volavka J. Bitter I, et al. Eur Psychiatry. 2005 Aug;20(5-6):403-8. doi: 10.1016/j.eurpsy.2005.01.009. Eur Psychiatry. 2005. PMID: 16084068 Clinical Trial.

6

Tardive Dyskinesia: analysis of outpatients with schizophrenia from Africa and the Middle East, Asia, Central and Eastern Europe, and Latin America.

Kasper S, Lowry AJ, Hodge A, Bitter I, Dossenbach M. Kasper S, et al. Among authors: bitter i. Schizophr Res. 2006 Jan 31;81(2-3):139-43. doi: 10.1016/j.schres.2005.07.032. Epub 2005 Oct 25. Schizophr Res. 2006. PMID: 16253478

7

Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study.

Bitter I, Treuer T, Dilbaz N, Oyffe I, Ciorabai EM, Gonzalez SL, Ruschel S, Salburg J, Dyachkova Y. Bitter I, et al. World J Biol Psychiatry. 2010 Oct;11(7):894-903. doi: 10.3109/15622975.2010.505663. World J Biol Psychiatry. 2010. PMID: 20653494 Free PMC article. Clinical Trial.

8

Effectiveness and tolerability of schizophrenia treatment in Central and Eastern Europe: results after 1 year from a prospective, observational study (IC-SOHO).

Treuer T, Anders M, Bitter I, Dobre G, Pecenak J, Dyachkova Y, Harrison G, O'Mahoney J. Treuer T, et al. Among authors: bitter i. Int J Psychiatry Clin Pract. 2006;10(2):78-90. doi: 10.1080/13651500500409663. Int J Psychiatry Clin Pract. 2006. PMID: 24940957

9

Intramuscular olanzapine and intramuscular haloperidol in acute schizophrenia: antipsychotic efficacy and extrapyramidal safety during the first 24 hours of treatment.

Wright P, Lindborg SR, Birkett M, Meehan K, Jones B, Alaka K, Ferchland-Howe I, Pickard A, Taylor CC, Roth J, Battaglia J, Bitter I, Chouinard G, Morris PL, Breier A. Wright P, et al. Among authors: bitter i. Can J Psychiatry. 2003 Dec;48(11):716-21. doi: 10.1177/070674370304801102. Can J Psychiatry. 2003. PMID: 14733451 Clinical Trial.

10

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.

Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I. Detke MJ, et al. Among authors: bitter i. Eur Neuropsychopharmacol. 2004 Dec;14(6):457-70. doi: 10.1016/j.euroneuro.2004.01.002. Eur Neuropsychopharmacol. 2004. PMID: 15589385 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

226 results

Search Page

Filters